| Emcure Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544210 |
NSE Symbol : EMCURE |
P/E(TTM) : 67.24 |
|
ISIN Demat : INE168P01015 |
Div & Yield% : 0.20 |
EPS(TTM) : 22.83 |
|
Book Value(₹) : 169.51 |
Market Cap(₹Cr) : 29,103.18 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,381.92 | 3,497.66 | 3,107.09 | 3,387.24 | 3,153.66 |
| Other Income | 142.48 | 138.26 | 125.35 | 132.68 | 111.91 |
| Stock Adjustments | 126.27 | 101.70 | -14.45 | 36.10 | 107.96 |
| Total Income | 4,650.67 | 3,737.62 | 3,217.99 | 3,556.02 | 3,373.53 |
| EXPENDITURE : | |||||
| Raw Materials | 2,133.68 | 1,464.67 | 1,199.25 | 1,354.99 | 1,354.36 |
| Power and Fuel Cost | 99.86 | 88.73 | 80.41 | 72.46 | 73.92 |
| Other Manufacturing Expenses | 275.56 | 209.89 | 192.67 | 219.39 | 142.20 |
| Selling and Administration Expenses | 473.67 | 532.82 | 443.20 | 263.11 | 341.49 |
| Miscellaneous Expenses | 119.95 | 164.27 | 95.59 | 114.78 | 73.58 |
| Employee Benefit Expenses | 782.31 | 706.41 | 649.18 | 603.95 | 550.96 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 765.64 | 570.83 | 557.69 | 927.36 | 837.02 |
| Interest | 112.96 | 166.09 | 166.83 | 145.14 | 123.34 |
| Gross Profit | 652.68 | 404.74 | 390.86 | 782.22 | 713.68 |
| Depreciation | 224.97 | 204.83 | 178.52 | 165.79 | 156.24 |
| Profit Before Tax | 427.71 | 199.91 | 212.34 | 616.43 | 557.44 |
| Current Tax | 112.71 | 38.58 | 53.10 | 168.72 | 141.13 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.13 | 0.50 | -0.83 | 0.89 | -4.15 |
| Reported Net Profit | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 |
| Extraordinary Items | 28.53 | -1.64 | -4.80 | 0.10 | -13.20 |
| Adjusted Net Profit | 288.60 | 162.47 | 164.86 | 446.71 | 433.68 |
| Adjustment below Net Profit | -1.21 | -5.34 | 4.06 | -0.79 | 0.11 |
| Profit/Loss Balance carried down | 1,695.08 | 1,593.84 | 1,465.89 | 1,877.11 | 1,474.61 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 54.26 | 36.17 | 857.24 | 18.09 |
| P & L Balance carried down | 2,011.00 | 1,695.08 | 1,593.84 | 1,465.89 | 1,877.11 |
| Dividend | 0.00 | 36.17 | 0.00 | 36.17 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 30.00 | 20.00 | 20.00 | 30.00 | 10.00 |
| Dividend Per Share(Rs) | 3.00 | 2.00 | 2.00 | 3.00 | 1.00 |
| Earnings Per Share-Unit Curr | 16.74 | 8.88 | 8.85 | 24.71 | 23.25 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 159.61 | 106.82 | 101.84 | 94.69 | 127.27 |
| Book Value(Adj)-Unit Curr | 159.61 | - | - | - | - |